{"id":"acotiamide","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Acetylcholinesterase","category":"target"},{"label":"ACHE","category":"gene"},{"label":"A03FA10","category":"atc"},{"label":"Active","category":"status"},{"label":"Nonulcer dyspepsia","category":"indication"},{"label":"Zeria","category":"company"},{"label":"Cholinergic Agents","category":"pharmacology"},{"label":"Cholinesterase Inhibitors","category":"pharmacology"},{"label":"Enzyme Inhibitors","category":"pharmacology"},{"label":"Gastrointestinal Agents","category":"pharmacology"},{"label":"Neurotransmitter Agents","category":"pharmacology"}],"phase":"marketed","safety":{"commonSideEffects":[]},"trials":[],"aliases":[],"company":"Zeria","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=ACOTIAMIDE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:21:01.762276+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T00:21:19.727597+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:21:10.184677+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ACOTIAMIDE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:21:10.390569+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2107723/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:21:11.073232+00:00"}},"allNames":"acofide","offLabel":[],"synonyms":["YM-443","Z-338","acotiamide","acotiamide hydrochloride","acotiamide hydrochloride hydrate","acofide","acotiamide HCl"],"timeline":[{"date":"2013-03-25","type":"positive","source":"DrugCentral","milestone":"PMDA approval (Zeria)"}],"aiSummary":"ACOTIAMIDE (Acofide), marketed by Zeria, is a nonulcer dyspepsia treatment that inhibits acetylcholinesterase, positioning it in a competitive market alongside metoclopramide and cisapride. Acofide's key strength lies in its distinct mechanism of action, which differentiates it from same-class competitors like metoclopramide and cisapride. The primary risk to Acofide is the key composition patent expiry in 2028, which could lead to increased competition from generics.","brandName":"Acofide","ecosystem":[{"indication":"Nonulcer dyspepsia","otherDrugs":[],"globalPrevalence":null}],"mechanism":{"target":"Acetylcholinesterase","targets":[{"gene":"ACHE","source":"DrugCentral","target":"Acetylcholinesterase","protein":"Acetylcholinesterase"}],"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Acofide acts as a reversible inhibitor of acetylcholinesterase, increasing the concentration of acetylcholine in the synaptic cleft and enhancing cholinergic transmission."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4908","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=ACOTIAMIDE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ACOTIAMIDE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T08:25:45.345640","_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T00:21:19.727680+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"metoclopramide","drugSlug":"metoclopramide","fdaApproval":"1979-02-07","patentExpiry":"Nov 17, 2038","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"cisapride","drugSlug":"cisapride","fdaApproval":"1993-07-29","patentStatus":"Unknown","relationship":"same-class"}],"genericName":"acotiamide","indications":{"approved":[{"name":"Nonulcer dyspepsia","source":"DrugCentral","snomedId":3696007,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"metoclopramide","brandName":"metoclopramide","genericName":"metoclopramide","approvalYear":"1979","relationship":"same-class"},{"drugId":"cisapride","brandName":"cisapride","genericName":"cisapride","approvalYear":"1993","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT04526119","phase":"PHASE3","title":"A Phase III Trial of Z-338 in Paediatric Patients With Functional Dyspepsia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Zeria Pharmaceutical","startDate":"2021-02-22","conditions":["Functional Dyspepsia"],"enrollment":55,"completionDate":"2026-06"},{"nctId":"NCT07449689","phase":"PHASE4","title":"Comparing Acotiamide and Itopride for the Management of Indigestion","status":"NOT_YET_RECRUITING","sponsor":"Aga Khan University","startDate":"2026-04","conditions":["Functioanl Dyspepsia","Post Prandial Distress Syndrome"],"enrollment":368,"completionDate":"2027-05"},{"nctId":"NCT07174297","phase":"PHASE3","title":"Acotiamide vs Itopride in Postprandial Distress Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Getz Pharma","startDate":"2025-10-30","conditions":["Postprandial Distress Syndrome"],"enrollment":152,"completionDate":"2027-04-30"},{"nctId":"NCT04697641","phase":"NA","title":"Helicobacter Pylori Eradication in Functional Dyspepsia","status":"COMPLETED","sponsor":"Sir Ganga Ram Hospital","startDate":"2017-09-01","conditions":["Dyspepsia","Helicobacter Pylori Infection"],"enrollment":202,"completionDate":"2019-05-31"},{"nctId":"NCT03402984","phase":"NA","title":"Effect of Acotiamide on Gastric Motility and Satiation in Healthy Volunteers","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2017-04-01","conditions":["Healthy"],"enrollment":20,"completionDate":"2017-12-04"},{"nctId":"NCT00102310","phase":"PHASE2","title":"YM443 in Subjects With Functional Dyspepsia","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2004-03-10","conditions":["Indigestion","Nausea"],"enrollment":416,"completionDate":"2006-03-11"},{"nctId":"NCT01973790","phase":"PHASE3","title":"Phase III, Long-term, Open-label Safety Study of Z-338","status":"COMPLETED","sponsor":"Zeria Pharmaceutical","startDate":"2014-03","conditions":["Dyspepsia"],"enrollment":207,"completionDate":"2017-04"},{"nctId":"NCT00323817","phase":"PHASE2","title":"To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia","status":"COMPLETED","sponsor":"Zeria Pharmaceutical","startDate":"2006-04","conditions":["Functional Dyspepsia"],"enrollment":282,"completionDate":"2009-10"},{"nctId":"NCT00764374","phase":"PHASE3","title":"A Long-term, Open-label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional Dyspepsia","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2008-08","conditions":["Dyspepsia","Functional Dyspepsia"],"enrollment":412,"completionDate":"2009-12"},{"nctId":"NCT00850746","phase":"PHASE1","title":"A Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy Adults","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2009-02","conditions":["Functional Dyspepsia"],"enrollment":80,"completionDate":"2009-04"},{"nctId":"NCT00761358","phase":"PHASE3","title":"To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia","status":"COMPLETED","sponsor":"Zeria Pharmaceutical","startDate":"2008-09","conditions":["Functional Dyspepsia"],"enrollment":820,"completionDate":"2010-08"},{"nctId":"NCT00458328","phase":"PHASE2","title":"The Effect of Z-338 in Subjects With Functional Dyspepsia","status":"COMPLETED","sponsor":"Zeria Pharmaceutical","startDate":"2007-04","conditions":["Functioanl Dyspepsia"],"enrollment":40,"completionDate":"2010-07"},{"nctId":"NCT00920998","phase":"PHASE1","title":"Effect of Food Intake on Pharmacokinetic Profiles of Z-338","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2009-03","conditions":["Healthy"],"enrollment":30,"completionDate":"2009-06"},{"nctId":"NCT00333372","phase":"PHASE2","title":"To Evaluate the Efficacy of Z-338 in Subjects With Functional Dyspepsia","status":"COMPLETED","sponsor":"Zeria Pharmaceutical","startDate":"2006-04","conditions":["Functional Dyspepsia"],"enrollment":440,"completionDate":""},{"nctId":"NCT00298194","phase":"PHASE2","title":"The Effects of Z-338 in Subjects With and Without Functional Dyspepsia","status":"COMPLETED","sponsor":"Zeria Pharmaceutical","startDate":"2006-02","conditions":["Dyspepsia"],"enrollment":52,"completionDate":""}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"D42OWK5383","CHEBI":"CHEBI:34523","INN_ID":"8506","UMLSCUI":"C4317155","chemblId":"CHEMBL2107723","ChEMBL_ID":"CHEMBL2107723","KEGG_DRUG":"D08838","DRUGBANK_ID":"DB12482","PUBCHEM_CID":"5282338","SECONDARY_CAS_RN":"773092-05-0","MESH_SUPPLEMENTAL_RECORD_UI":"C410959"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"present","companyName":"Zeria","relationship":"Current Owner"}],"publicationCount":119,"therapeuticAreas":["Neuroscience"],"atcClassification":{"source":"DrugCentral","atcCode":"A03FA10","allCodes":["A03FA10"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"Zeria","companyId":"zeria","modality":"Small molecule","firstApprovalDate":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"JP","regulator":"PMDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Acofide","application_number":"Acofide"}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T00:21:19.727680+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}